BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sakane T, Murase T, Okuda K, Saida K, Masaki A, Yamada T, Saito Y, Nakanishi R, Inagaki H. A mutation analysis of the EGFR pathway genes, RAS, EGFR, PIK3CA, AKT1 and BRAF, and TP53 gene in thymic carcinoma and thymoma type A/B3. Histopathology 2019;75:755-66. [PMID: 31179560 DOI: 10.1111/his.13936] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Tateo V, Manuzzi L, Parisi C, De Giglio A, Campana D, Pantaleo MA, Lamberti G. An Overview on Molecular Characterization of Thymic Tumors: Old and New Targets for Clinical Advances. Pharmaceuticals (Basel) 2021;14:316. [PMID: 33915954 DOI: 10.3390/ph14040316] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Arjonen A, Mäkelä R, Härmä V, Rintanen N, Kuopio T, Kononen J, Rantala JK. Image-based ex vivo drug screen to assess targeted therapies in recurrent thymoma. Lung Cancer 2020;145:27-32. [DOI: 10.1016/j.lungcan.2020.04.036] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
3 Zu Y, Luo Y, Li C, Zhao J, He T, Shi X, Li X. Complete remission following icotinib administration in an advanced ectopic thymic carcinoma patient harbouring the EGFR exon 19 deletion. J Gene Med 2021;23:e3340. [PMID: 33835620 DOI: 10.1002/jgm.3340] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Liu D, Zhang P, Zhao J, Yang L, Wang W. Identification of Molecular Characteristics and New Prognostic Targets for Thymoma by Multiomics Analysis. Biomed Res Int 2021;2021:5587441. [PMID: 34104648 DOI: 10.1155/2021/5587441] [Reference Citation Analysis]
5 Soomro IN. Pathology of thymoma-where are we today? J Thorac Dis 2020;12:7545-52. [PMID: 33447445 DOI: 10.21037/jtd-2019-thym-04] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Roden AC, Szolkowska M. Common and rare carcinomas of the thymus. Virchows Arch 2021;478:111-28. [PMID: 33389148 DOI: 10.1007/s00428-020-03000-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Xu S, Li X, Zhang H, Zu L, Yang L, Shi T, Zhu S, Lei X, Song Z, Chen J. Frequent Genetic Alterations and Their Clinical Significance in Patients With Thymic Epithelial Tumors. Front Oncol 2021;11:667148. [PMID: 34307137 DOI: 10.3389/fonc.2021.667148] [Reference Citation Analysis]
8 Sakane T, Murase T, Okuda K, Masaki A, Nakanishi R, Inagaki H. Expression of cancer testis antigens in thymic epithelial tumors. Pathol Int 2021;71:471-9. [PMID: 33902161 DOI: 10.1111/pin.13103] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Sakane T, Sakamoto Y, Masaki A, Murase T, Okuda K, Nakanishi R, Inagaki H. Mutation Profile of Thymic Carcinoma and Thymic Neuroendocrine Tumor by Targeted Next-generation Sequencing. Clin Lung Cancer 2021;22:92-99.e4. [PMID: 33414055 DOI: 10.1016/j.cllc.2020.11.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]